Eli Lilly and Company today announced it will introduce a lower-priced version of Humalog®(insulin lispro injection 100 units/mL) in the U.S. The
Novo Nordisk recently submitted label updates to the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for
Dexcom, Inc. announced last week that the company has received Health Canada approval for its next-generation Dexcom G6 CGM System for people with
The University of Virginia Health System is expanding its telehealth capacity to help patients across Virginia better prevent or manage chronic
A University California, San Francisco study of human and mouse pancreatic tissue suggests a new origin story for Type 1 diabetes. The findings flip
Diabetes care is at the forefront of many new innovations, from monitoring devices that synch with apps to devices that track and administer the
dLife is proud to bring you an exclusive conversation with prominent executive, Carl S. Armato, in which he shares with us details about his
Abbott and Novo Nordisk today announced a deal that connects two key technologies: Continuous glucose monitoring (CGM) and connected insulin pens.
The American Diabetes Association (ADA) announced recipients of this year’s prestigious Pathway to Stop Diabetes grants, totaling $4.875 million
Senseonics Holdings, Inc., a company developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: